Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 6, 2006, Pages

  Petnehazy, Thomas ^a,b   Cooper, Dianne ^a   Stokes, Karen Y ^a   Russell, Janice ^a   Wood, Katherine C ^a   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Angiotensin II type 1 receptor expression; Endothelium; Leukocytes; Microcirculation; Platelets

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTESTINE ISCHEMIA; LEUKOCYTE; LEUKOCYTE ADHERENCE; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPERFUSION INJURY; THROMBOCYTE ADHESION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; INTESTINES; MICE; MICE, INBRED C57BL; MICROCIRCULATION; REPERFUSION INJURY;

EID: 33646873488     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00578.2005     Document Type: Article

References (35)

1. Alvarez A, Cerda-Nicolas M, Naim Abu Nabah Y, Mata M, Issekutz AC, Panes J, Lobb RR, and Sanz MJ. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 104: 402-408, 2004.
2. Alvarez A and Sanz MJ. Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. J Leukoc Biol 70: 199-206, 2001.
3. Blake DR, Winyard PG, and Marok R. The contribution of hypoxia-reperfusion injury to inflammatory synovitis: the influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann NY Acad Sci 723: 308-317, 1994.
4. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, and Kranzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res 42: 415-423, 2005.
5. Carden DL and Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 190: 255-266, 2000.
6. Cheng ZJ, Vapaatalo H, and Mervaala E. Angiotensin II and vascular inflammation. Med Sci 11: RA194-205, 2005.
7. Cooper D, Chitman KD, Williams MC, and Granger DN. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 284: G1027-G1033, 2003.
8. Cooper D, Russell J, Chitman KD, Williams MC, Wolf RE, and Granger DN. Leukocyte dependence of platelet adhesion in postcapillary venules. Am J Physiol Heart Circ Physiol 286: H1895-H1900, 2004.
9. Costanzo A, Moretti F, Burgio VL, Bravi C, Guido F, Levrero M, and Puri PL. Endothelial activation by angiotensin II through NF-κB and p38 pathways: Involvement of NF-κB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 195: 402-410, 2003.
10. Cowling RT, Zhang X, Reese VC, Iwata M, Gurantz D, Dillmann WH, and Greenberg BH. Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol 289: H1176-H1183, 2005.
11. El Bekay R, Alvarez M, Monteseirin J, Alba G, Chacon P, Vega A, Martin-Nieto J, Jimenez J, Pintado E, Bedoya FJ, and Sobrino F. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-B. Blood 102: 662-671, 2003.
12. Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA, and Granger DN. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res 79: 560-569, 1996.
13. Grafe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, Graf K, Loebe M, Gaehtgens P, and Fleck E. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 81: 804-811, 1997.
14. Granger DN and Stokes KY. Differential regulation of leukocyte- endothelial cell interactions. In: Endothelial Cells in Health and Disease, edited by Aird WC. Boca Raton, FL: Taylor & Francis Group, 2005, p. 229-244.
15. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-27, 2000.
16. Gunther S, Gimbrone MA Jr, and Alexander RW. Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery. Circ Res 47: 278-286, 1980.
17. Ishikawa M, Cooper D, Russell J, Salter JW, Zhang JH, Nanda A, and Granger DN. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 34: 1777-1782, 2003.
18. Khandoga A, Biberthaler P, Enders G, Teupser D, Axmann S, Luchting B, Hutter J, Messmer K, and Krombach F. P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo. Shock 18: 529-535, 2002.
19. Korthuis RJ, Gute DC, Blecha F, and Ross CR. PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. Am J Physiol Heart Circ Physiol 277: H1007-H1013, 1999.
20. Lopez-Farre A, Sanchez de Miguel L, Monton M, Jimenez A, Lopez-Bloya A, Gomez J, Nunez A, Rico L, and Casado S. Angiotensin II AT(1) receptor antagonists and platelet activation. Nephrol Dial Transplant 16, Suppl 1: 45-49, 2001.
21. Mervaala EM, Muller DN, Park JK, Schmidt F, Lohn M, Breu V, Dragun D, Ganten D, Haller H, and Luft FC. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 33: 389-395, 1999.
22. Panes J, Perry M, and Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 126: 537-550, 1999.
23. Petnehazy T, Stokes KY, Russell JM, and Granger DN. Angiotensin II type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules. Hypertension 45: 209-215, 2005.
24. Petnehazy T, Stokes KY, Wood KC, Russell J, and Granger DN. Role of Blood Cell-Associated AT1 Receptors in the Microvascular Responses to Hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2005.
25. Piqueras L, Kubes P, Alvarez A, O'Connor E, Issekutz AC, Esplugues JV, and Sanz MJ. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation 102: 2118-2123, 2000.
26. Plumb RD, El-Sherbeeny NA, Dixon LJ, Hughes SM, Devine AB, Leahey WJ, and McVeigh GE. NAD(P)H-dependent superoxide production in platelets: the role of angiotensin II and protein kinase C. Clin Biochem 38: 607-613, 2005.
27. Prasad A, Koh KK, Schenke WH, Mincemoyer R, Csako G, Fleischer TA, Brown M, Selvaggi TA, and Quyyumi AA. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis. Am Heart J 142: 248-253, 2001.
28. Riaz AA, Wang Y, Schramm R, Sato T, Menger MD, Jeppsson B, and Thorlacius H. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 18: 881-883, 2004.
29. Ruiz-Ortega M, Lorenzo O, and Egido J. Angiotensin III increases MCP-1 and activates NF-κB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int 57: 2285-2298, 2000.
30. Serebruany VL, Malinin AI, Lowry DR, Sane DC, Webb RL, Gottlieb SO, O'Connor CM, and Hennekens CH. Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefits. J Cardiovasc Pharmacol 43: 677-684, 2004.
31. Tailor A, Cooper D, and Granger DN. Platelet-vessel wall interactions in the microcirculation. Microcirculation 12: 275-285, 2005.
32. Tailor A and Granger DN. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol 23: 675-680, 2003.
33. Wood KC, Hebbel RP, and Granger DN. Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice. Am J Physiol Heart Circ Physiol 286: H1608-H1614, 2004.
34. Yao Y, Yu Y, Wu Y, Shi Z, and Sheng Z. The role of gut as a cytokine-generating organ in remote organ dysfunction after intestinal ischemia and reperfusion. Chin Med J (Engl) 111: 514-518, 1998.
35. Yilmaz EN, Vahl AC, van Rij GL, Vink GQ, Lange-De Klerk ES, Brom HL, and Rauwerda JA. The renin-angiotensin system in swine during hypovolaemic shock combined with low-flow ischaemia of the sigmoid colon. Cardiovasc Surg 7: 539-544, 1999.